Get the latest tech news
Revolutionary Alzheimer’s Treatments Can’t Help Patients Who Go Undiagnosed
It’s a question of when, not if, highly effective treatments become available, says the CEO of Alzheimer’s Research UK. But that doesn’t solve the problem of one-third of dementia patients still going undiagnosed.
Currently, there are more than 140 clinical trials ongoing for a variety of potential Alzheimer’s treatments, ranging from compounds capable of removing toxic proteins to drugs that can restore the function of damaged brain cells. This could be changed by the introduction of accurate digital cognitive tests, for instance, which would allow patients to be evaluated in real-time and access care faster. “The retina is a particularly attractive target because it’s closely related to brain tissue and can be examined noninvasively during routine eye checks,” Evans says.
Or read this on Wired
